African Americans with Glaucoma: Structure and Function
患有青光眼的非洲裔美国人:结构和功能
基本信息
- 批准号:6951138
- 负责人:
- 金额:$ 173.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-30 至 2007-08-31
- 项目状态:已结题
- 来源:
- 关键词:African Americanblindnesscaucasian Americancell morphologyclinical researchcooperative studyeye disorder diagnosiseye fundus photographyglaucomahuman subjectlongitudinal human studymedical complicationnerve injuryoptic nervepathologic processperimetryracial /ethnic differencetomographyvision disordersvision testsvisual fields
项目摘要
DESCRIPTION (provided by applicant): Glaucoma, which is 5 times more likely to occur in Blacks than Whites, is the leading cause of irreversible blindness in Blacks. Little is known about whether new diagnostic tests including vision function specific tests and optic disc and retinal nerve fiber layer imaging can improve our ability to detect and monitor glaucoma in the Black population. Purpose: To systematically assess and compare new diagnostic techniques in Black and White participants. Aims: To compare differences in visual function tests and measures of optic nerve structure in normal, ocular hypertensive, and glaucomatous Black and White participants, to determine whether function specific perimetry tests show improved diagnosis in Blacks as they do in Whites, and to compare the rate and patterns of progression of glaucomatous damage in the two racial groups. Participants: 125 normal and 275 Black participants with glaucoma. Methods: Black participants will be recruited primarily from New York Eye and Ear Infinnary and the University of Alabama Glaucoma Service. White participants are recruited under separate funding at UC San Diego. UC San Diego serves as a Reading Center for data processing, quality control and analysis for this study. The glaucomatous eyes will be followed with annual testing for 5 years. Visual fields will include standard clinical perimetry, and two function-specific tests, Short-wavelength Automated Perimetry and Frequency Doubling Technology Perimetry. Optic nerve structure will be qualitatively evaluated with stereoscopic fundus photography and quantitatively using the Heidelberg Retina Tomograph and Optical Coherence Tomograph. Comparisons between Blacks and Whites will be made on each test and between the measures of function and structure. Importance: At study conclusion, practitioners should understand any differences in visual function and optic nerve structure between White and Black patients and how to account for them when interpreting the results. A greater understanding of the importance of race for development and progression of glaucoma will result leading to more precise endpoints for future clinical trials with this at-risk minority population.
描述(由申请人提供):青光眼在黑人中发生的可能性是白人的 5 倍,是黑人不可逆性失明的主要原因。人们对新的诊断测试(包括视觉功能特异性测试以及视盘和视网膜神经纤维层成像)是否可以提高我们检测和监测黑人青光眼的能力知之甚少。目的:系统评估和比较黑人和白人参与者的新诊断技术。目的:比较正常、高眼压和青光眼黑人和白人参与者的视功能测试和视神经结构测量的差异,以确定功能特异性视野检查是否显示黑人与白人的诊断得到改善,并比较两个种族组中青光眼损伤进展的速度和模式。 参与者:125 名正常人和 275 名患有青光眼的黑人参与者。方法:黑人参与者将主要从纽约眼耳医院和阿拉巴马大学青光眼服务中心招募。 白人参与者是在加州大学圣地亚哥分校的单独资助下招募的。加州大学圣地亚哥分校作为本研究的数据处理、质量控制和分析的阅读中心。青光眼眼睛将在 5 年内每年进行一次检查。视野将包括标准临床视野检查和两项特定功能测试:短波长自动视野检查和倍频技术视野检查。 将通过立体眼底摄影对视神经结构进行定性评估,并使用海德堡视网膜断层扫描仪和光学相干断层扫描仪进行定量评估。将在每次测试以及功能和结构测量之间进行黑人和白人之间的比较。 重要性:在研究结论中,从业者应了解白人和黑人患者之间视觉功能和视神经结构的差异,以及在解释结果时如何解释这些差异。更好地了解种族对青光眼发生和进展的重要性将为未来针对这一高危少数群体的临床试验带来更精确的终点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAMELA A SAMPLE其他文献
PAMELA A SAMPLE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAMELA A SAMPLE', 18)}}的其他基金
African Americans with Glaucoma: Structure and Function
患有青光眼的非洲裔美国人:结构和功能
- 批准号:
6534707 - 财政年份:2002
- 资助金额:
$ 173.45万 - 项目类别:
African Americans with Glaucoma: Structure and Function
患有青光眼的非洲裔美国人:结构和功能
- 批准号:
6804697 - 财政年份:2002
- 资助金额:
$ 173.45万 - 项目类别:
African Descent and Glaucoma Evaluation Study (ADAGES)
非洲人后裔和青光眼评估研究 (ADAGES)
- 批准号:
7123821 - 财政年份:2002
- 资助金额:
$ 173.45万 - 项目类别:
African Americans with Glaucoma: Structure and Function
患有青光眼的非洲裔美国人:结构和功能
- 批准号:
6665030 - 财政年份:2002
- 资助金额:
$ 173.45万 - 项目类别:
African Descent and Glaucoma Evaluation Study (ADAGES)
非洲人后裔和青光眼评估研究 (ADAGES)
- 批准号:
7613614 - 财政年份:2002
- 资助金额:
$ 173.45万 - 项目类别:
African Descent And Glaucoma Evaluation Study (ADAGES)
非洲人后裔与青光眼评估研究 (ADAGES)
- 批准号:
7313869 - 财政年份:2002
- 资助金额:
$ 173.45万 - 项目类别:
VISUAL FUNCTION IN GLAUCOMA AND OCULAR HYPERTENSION
青光眼和高眼压症的视觉功能
- 批准号:
6384611 - 财政年份:1990
- 资助金额:
$ 173.45万 - 项目类别:
VISUAL FUNCTION IN GLAUCOMA AND OCULAR HYPERTENSION
青光眼和高眼压症的视觉功能
- 批准号:
7117490 - 财政年份:1990
- 资助金额:
$ 173.45万 - 项目类别:
Diagnostic Innovations in Glaucoma Study: Visual Function
青光眼研究的诊断创新:视觉功能
- 批准号:
7648063 - 财政年份:1990
- 资助金额:
$ 173.45万 - 项目类别:
相似国自然基金
盲人脑网络可塑性的磁共振影像研究
- 批准号:30900476
- 批准年份:2009
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Prime editing for Crumbs homologue 1 (CRB1) Inherited Retinal Dystrophies
Crumbs 同源物 1 (CRB1) 遗传性视网膜营养不良的 Prime 编辑
- 批准号:
10636325 - 财政年份:2023
- 资助金额:
$ 173.45万 - 项目类别:
Development of a novel depot delivery system for a glaucoma therapeutic
开发用于青光眼治疗的新型储库递送系统
- 批准号:
10699791 - 财政年份:2023
- 资助金额:
$ 173.45万 - 项目类别:
Planning the VICTORY (VIsual ComplicaTions Of PrematuRitY) Study
规划 VICTORY(早产儿视觉并发症)研究
- 批准号:
10645471 - 财政年份:2023
- 资助金额:
$ 173.45万 - 项目类别:
In Vivo Function and Metabolism Evaluation of Glaucomatous RGCs by Two-Photon Scanning Laser Ophthalmology
双光子扫描激光眼科评价青光眼 RGC 的体内功能和代谢
- 批准号:
10660761 - 财政年份:2023
- 资助金额:
$ 173.45万 - 项目类别:
Reversal of Ovarian Aging in Mice Through AAV-mediated Oocyte Reprogramming in vivo
通过 AAV 介导的体内卵母细胞重编程逆转小鼠卵巢衰老
- 批准号:
10723227 - 财政年份:2023
- 资助金额:
$ 173.45万 - 项目类别:
Novel Polymer-antibody Conjugates as Long-acting Therapeutics for Ocular Diseases
新型聚合物-抗体缀合物作为眼部疾病的长效治疗药物
- 批准号:
10760186 - 财政年份:2023
- 资助金额:
$ 173.45万 - 项目类别:
Genome Editing Therapy for Usher Syndrome Type 3
针对 3 型亚瑟综合症的基因组编辑疗法
- 批准号:
10759804 - 财政年份:2023
- 资助金额:
$ 173.45万 - 项目类别:
Developing a novel disease-targeted anti-angiogenic therapy for CNV
开发针对 CNV 的新型疾病靶向抗血管生成疗法
- 批准号:
10726508 - 财政年份:2023
- 资助金额:
$ 173.45万 - 项目类别:
Personalizing Circumpapillary Retinal Nerve Fiber Layer Thickness Norms for Glaucoma
个性化青光眼环视乳头视网膜神经纤维层厚度标准
- 批准号:
10728042 - 财政年份:2023
- 资助金额:
$ 173.45万 - 项目类别:
Mechanisms of structural plasticity, client interactions, and co-aggregation of the lens ⍺-crystallins
晶状体α-晶状体的结构可塑性、客户相互作用和共聚集机制
- 批准号:
10709482 - 财政年份:2023
- 资助金额:
$ 173.45万 - 项目类别: